논문 다인바이오가 쌓아올린 연구 실적 입니다.
  • [Neoagarooligosaccharides prevent septic shock by modulating A20- and cyclooxygenase-2-mediated interleukin-10 secretion in a septic-shock mouse model]
    Biochemical and Biophysical Research Communications, 2017, 486(4): 998-1004.
  • [Anti-obesity and anti-diabetic effect of neoagarooligosaccharides on high-fat diet-induced obesity in mice] Marine Drugs, 2017, 15(4):90.
  • [Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity] BMB report,
    2017, 50(5):263-268.
  • [In vitro and in vivo investigation for biological activities of neoagarooligosaccharides prepared by hydrolyzing agar with B-agarase] Biotechnology and Bioprocess Engineering,
    2017, 22:489-496.
  • [Toxicological evaluation of neoagarooligosaccharides prepared by enzymatic hydrolysis of agar] Regulatory Toxicology and Pharmacology, 2017, 90:9-21.
  • [Neoagarooligosaccharide enhances the level and efficiency of the LDL receptor and contributes to the improvement of cholesterol homeostasis] Journal of Functional Foods, 2017, 38:529-539.
  • [Non-targeted metabolomics unravels a media-dependent prodiginines production pathway in Streptomyces coelicolor A3(2)] PLOS ONE, 2018, 13(10), e0207541.
  • [Safety evaluation of B-agarase preparations from Streptomyces coelicolor A3(2)] Regulatory Toxicology and Pharmacology, 2019, 101:142-155.
  • [Implications of agar and agarase in industrial applications of sustainable marine biomass] Applied Microbiology and Biotechnology, 2020, 104:2815-2832.
  • [Hepatoprotective effect of neoagarooligosaccharide via activation of Nrf2 and enhanced antioxidant efficacy] Biological and Pharmaceutical Bulletin, 2020, DOI:10.1248/bpb.b19-00697
  • [Microfluidic skin chip with vasculature for recapitulating the immune response of the skin tissue] BIOTECHNOLOGY AND BIOENGINEERING, 2020, D01:10.1002/bit.27320
  • Anticiral efficacy of orally delivered neogagrohexaose, a nonconventional TLR4 agonist, against norvorius infection in mice. Biomaterials 2020. (263) 120391
  • Neoagarooligosaccharide Protects Against Hepatic Fibrosis Via inhibition of TGF‐β/Smad Signaling Pathway. Int. J. Mol. Sci. 2021, 22,2041.
사업자등록번호: 135-81-33747 / 통신판매업신고 제 2007-1187 호 / 대표이사 : 이제현
본사/연구소 : 경기도 성남시 중원구 사기막골로45번길 14, B동 B204호~B206호 (상대원동, 우림라이온스밸리 2차)
생명과학 사업부 : 경기도 성남시 수정구 위례광장로 5, 314호 (창곡동, 위례우남역아이파크)
Tel : 031-748-8166 / Fax : 031-748-8265 / E-mail :
Copyright©2016 DYNEBIO INC. All right reserved. Administrator Login